|
Volumn 44, Issue 3, 2008, Pages 175-181
|
Venous thromboembolism and prophylaxis in cancer patients.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
LOW MOLECULAR WEIGHT HEPARIN;
WARFARIN;
ADULT;
AGE;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
INCIDENCE;
MALE;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK;
RISK FACTOR;
TIME;
VENOUS THROMBOEMBOLISM;
ADULT;
AGE FACTORS;
ANTICOAGULANTS;
FEMALE;
FIBRINOLYTIC AGENTS;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
RISK FACTORS;
TIME FACTORS;
VENOUS THROMBOEMBOLISM;
WARFARIN;
MLCS;
MLOWN;
|
EID: 43049172054
PISSN: None
EISSN: 16489144
Source Type: Journal
DOI: 10.3390/medicina44030022 Document Type: Review |
Times cited : (10)
|
References (34)
|